Paperless Partograph for Management of Low Risk Labor

Paperless partograph is a technique used for monitoring the progress of labor before delivery, and arriving at the accurate time to intervene for ensuring a safe delivery.

The study will be carried out to find out the effectiveness of paperless partograph in management of labor and its effect on maternal and neonatal outcomes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Normal Labor

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age: 18 to 40 years
Gestational age 38-42 weeks
Singleton pregnancy
Vertex presentation
Women who will accept to participate in the study

Exclusion criteria

Malpresentation
Induced labour
Multiple pregnancy
Medical diseases with pregnancy

Treatment and study plan

modified partograph

Procedure

paperless partograph

Procedure

Primary outcomes

Duration of active phase of labor

Time frame: 12 hours

calculated in hours between cervical dilatation more than 3 cm till fully dilated

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

A Randomized Clinical Trial of Paperless Versus Modified World Health Organization Partograph in Management of First Stage of Labour

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Mar 21, 2016
Registry last updated: Aug 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed